Trinity Biotech Files 6-K, Reports Under Form 20-F
Ticker: TRIB · Form: 6-K · Filed: Dec 18, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Dec 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, reporting-status
Related Tickers: TRIB
TL;DR
Trinity Biotech (TRIB) filed a 6-K, confirming 20-F reporting. Standard procedure.
AI Summary
Trinity Biotech plc filed a Form 6-K on December 18, 2024, reporting as a foreign private issuer. The filing indicates the company is submitting its annual reports under Form 20-F. The principal executive office is located in Bray, Co. Wicklow, Ireland.
Why It Matters
This filing confirms Trinity Biotech's reporting status as a foreign private issuer and its adherence to SEC regulations by filing under Form 20-F.
Risk Assessment
Risk Level: low — This is a routine filing confirming reporting status and not indicative of new material events.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0001178913-24-004008 (accession_number) — Filing identifier
- 20241218 (date) — Filing date
- Form 6-K (document_type) — Filing type
- Form 20-F (document_type) — Annual report form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as a foreign private issuer, specifically indicating that Trinity Biotech plc files its annual reports under Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on December 18, 2024.
Where is Trinity Biotech plc's principal executive office located?
Trinity Biotech plc's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Under which SEC Act is this report filed?
This report is filed under the Securities Exchange Act of 1934.
Does Trinity Biotech plc file its annual reports in paper format?
The filing indicates that Trinity Biotech plc files its annual reports under cover of Form 20-F, and does not explicitly state submission in paper format under Regulation S-T Rule 101(b)(1) or 101(b)(7).
Filing Stats: 328 words · 1 min read · ~1 pages · Grade level 14.5 · Accepted 2024-12-18 12:02:58
Filing Documents
- zk2432474.htm (6-K) — 16KB
- exhibit_99-1.htm (EX-99.1) — 11KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-004008.txt ( ) — 153KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: December 18, 2024